Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
BH3 mimetic; Bcl-2 inhibitor.
Topoisomerase II inhibitor, RPA modulator.
Non-specific caspase inhibitor used to prevent ...
Triadimefon metabolite; mutagen.
CB2 receptor antagonist.
Polycationic aminoglycoside; protein translatio...
Nitroimidazole, binds DNA; nucleic acid synthes...
VEGFR inhibitor.
mAChR agonist, selective for M2.
Imidazoline derivative; α1-adrenergic agonist,...
Commercial food additive, antioxidant.
Pleuromutilin
Endogenous peptide; actin polymerization inhibi...
Flavonol glycoside originally found in Epimediu...
Synthetic progestogen, orexigenic.
Taxane synthesis intermediate.
Vitamin E component
Phenylpyrazoleanilide; IL-17 production inhibit...
CDK7 inhibitor
Peptide, binds fibronectin.